Ute Hegenbart

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 42

Top Venues

Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis

Journal of the American Society of Nephrology : JASN

University Hospital Heidelberg

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University Hospital Heidelberg Apr 01 2004

Germany

Consultant :: Amyloidosis Center

Publications

Marco Basset, Stefan O Schönland, Laura Obici, Janine Günther, Eloisa Riva, Tobias Dittrich, Paolo Milani, Virginia Valeria Ferretti, Ettore Pasquinucci, Andrea Foli, Christoph Kimmich, Martina Nanci, Claudia Bellofiore, Francesca Benigna, Jörg Beimler, Pietro Benvenuti, Francesca Fabris, Roberta Mussinelli, Mario Nuvolone, Catherine Klersy, Riccardo Albertini, Giampaolo Merlini, Ute Hegenbart, Giovanni Palladini, Norbert Blank
Development and Validation of Staging Systems for AA Amyloidosis. Journal of the American Society of Nephrology : JASN 35 (6) (2024)
Sara Karimi-Farsijani, Peter Benedikt Pfeiffer, Sambhasan Banerjee, Julian Baur, Lukas Kuhn, Niklas Kupfer, Ute Hegenbart, Stefan O Schönland, Sebastian Wiese, Christian Haupt, Matthias Schmidt, Marcus Fändrich
Light chain mutations contribute to defining the fibril morphology in systemic AL amyloidosis. Nature communications 15 (1) (2024)
Monique C Minnema, Kazem Nasserinejad, Ute Hegenbart, Paula F Ypma, Ka Lung Wu, Marie José Kersten, Sandra Croockewit, Sonja Zweegman, Lidwine W Tick, Annemiek Broijl, Harry Koene, Gerard M J Bos, Pieter Sonneveld, Stefan O Schönland
HOVON 104, long-term follow-up of bortezomib-dexamethasone induction therapy followed by autologous stem cell transplantation in newly diagnosed AL amyloidosis patients. EJHaem 5 (4) (2024)
Marco Basset, Stefan O Schönland, Laura Obici, Janine Günther, Eloisa Riva, Tobias Dittrich, Paolo Milani, Virginia Valeria Ferretti, Ettore Pasquinucci, Andrea Foli, Christoph Kimmich, Martina Nanci, Claudia Bellofiore, Francesca Benigna, Jörg Beimler, Pietro Benvenuti, Francesca Fabris, Roberta Mussinelli, Mario Nuvolone, Catherine Klersy, Riccardo Albertini, Giampaolo Merlini, Ute Hegenbart, Giovanni Palladini, Norbert Blank
Development and Validation of Staging Systems for AA Amyloidosis. Journal of the American Society of Nephrology : JASN 35 (6) (2024)
Marco Basset, Stefan O Schönland, Laura Obici, Janine Günther, Eloisa Riva, Tobias Dittrich, Paolo Milani, Virginia Valeria Ferretti, Ettore Pasquinucci, Andrea Foli, Christoph Kimmich, Martina Nanci, Claudia Bellofiore, Francesca Benigna, Jörg Beimler, Pietro Benvenuti, Francesca Fabris, Roberta Mussinelli, Mario Nuvolone, Catherine Klersy, Riccardo Albertini, Giampaolo Merlini, Ute Hegenbart, Giovanni Palladini, Norbert Blank
Development and Validation of Staging Systems for AA Amyloidosis. Journal of the American Society of Nephrology : JASN 35 (6) (2024)
Rajshekhar Chakraborty, Saurabh Zanwar, Ute Hegenbart, Divaya Bhutani, Morie A Gertz, Angela Dispenzieri, Shaji K Kumar, Anita D'Souza, Anannya Patwari, Andrew J Cowan, Gui Zhen Chen, Paolo Milani, Giovanni Palladini, Vaishali Sanchorawala, Geethika Bodanapu, Stefan Schönland, Suzanne Lentzsch, Eli Muchtar
Prognostic impact of cytogenetic abnormalities by FISH in AL amyloidosis with daratumumab-based frontline therapy. Blood (2024)
Marco Basset, Stefan O Schönland, Laura Obici, Janine Günther, Eloisa Riva, Tobias Dittrich, Paolo Milani, Virginia Valeria Ferretti, Ettore Pasquinucci, Andrea Foli, Christoph Kimmich, Martina Nanci, Claudia Bellofiore, Francesca Benigna, Jörg Beimler, Pietro Benvenuti, Francesca Fabris, Roberta Mussinelli, Mario Nuvolone, Catherine Klersy, Riccardo Albertini, Giampaolo Merlini, Ute Hegenbart, Giovanni Palladini, Norbert Blank
Development and Validation of Staging Systems for AA Amyloidosis. Journal of the American Society of Nephrology : JASN 35 (6) (2024)
Fabian Aus dem Siepen, Selina Hein, Eva Hofmann, Christian Nagel, Stéphanie K Schwarting, Ute Hegenbart, Stefan O Schönland, Markus Weiler, Norbert Frey, Arnt V Kristen
Prognostic Value of Standard Heart Failure Medication in Patients with Cardiac Transthyretin Amyloidosis. Journal of clinical medicine 13 (8) (2024)
Marco Basset, Stefan O Schönland, Laura Obici, Janine Günther, Eloisa Riva, Tobias Dittrich, Paolo Milani, Virginia Valeria Ferretti, Ettore Pasquinucci, Andrea Foli, Christoph Kimmich, Martina Nanci, Claudia Bellofiore, Francesca Benigna, Jörg Beimler, Pietro Benvenuti, Francesca Fabris, Roberta Mussinelli, Mario Nuvolone, Catherine Klersy, Riccardo Albertini, Giampaolo Merlini, Ute Hegenbart, Giovanni Palladini, Norbert Blank
Development and Validation of Staging Systems for AA Amyloidosis. Journal of the American Society of Nephrology : JASN (2024)
Monique C Minnema, Kazem Nasserinejad, Ute Hegenbart, Paula F Ypma, Ka Lung Wu, Marie José Kersten, Sandra Croockewit, Sonja Zweegman, Lidwine W Tick, Annemiek Broijl, Harry Koene, Gerard M J Bos, Pieter Sonneveld, Stefan O Schönland
HOVON 104, long-term follow-up of bortezomib-dexamethasone induction therapy followed by autologous stem cell transplantation in newly diagnosed AL amyloidosis patients. EJHaem 5 (4) (2024)
Sara Karimi-Farsijani, Peter Benedikt Pfeiffer, Sambhasan Banerjee, Julian Baur, Lukas Kuhn, Niklas Kupfer, Ute Hegenbart, Stefan O Schönland, Sebastian Wiese, Christian Haupt, Matthias Schmidt, Marcus Fändrich
Light chain mutations contribute to defining the fibril morphology in systemic AL amyloidosis. Nature communications 15 (1) (2024)
Fabian Aus dem Siepen, Selina Hein, Eva Hofmann, Christian Nagel, Stéphanie K Schwarting, Ute Hegenbart, Stefan O Schönland, Markus Weiler, Norbert Frey, Arnt V Kristen
Prognostic Value of Standard Heart Failure Medication in Patients with Cardiac Transthyretin Amyloidosis. Journal of clinical medicine 13 (8) (2024)
Marco Basset, Stefan O Schönland, Laura Obici, Janine Günther, Eloisa Riva, Tobias Dittrich, Paolo Milani, Virginia Valeria Ferretti, Ettore Pasquinucci, Andrea Foli, Christoph Kimmich, Martina Nanci, Claudia Bellofiore, Francesca Benigna, Jörg Beimler, Pietro Benvenuti, Francesca Fabris, Roberta Mussinelli, Mario Nuvolone, Catherine Klersy, Riccardo Albertini, Giampaolo Merlini, Ute Hegenbart, Giovanni Palladini, Norbert Blank
Development and Validation of Staging Systems for AA Amyloidosis. Journal of the American Society of Nephrology : JASN (2024)
Maximilian Steinebrei, Julian Baur, Anaviggha Pradhan, Niklas Kupfer, Sebastian Wiese, Ute Hegenbart, Stefan O Schönland, Matthias Schmidt, Marcus Fändrich
Common transthyretin-derived amyloid fibril structures in patients with hereditary ATTR amyloidosis. Nature communications 14 (1) (2023)
Giovanni Palladini, Stefan O Schönland, Giampaolo Merlini, Paolo Milani, Arnaud Jaccard, Frank Bridoux, Meletios- Athanasios Dimopoulos, Sriram Ravichandran, Ute Hegenbart, Wilfried Roeloffzen, M Teresa Cibeira, Hermine Agis, Monique C Minnema, Rui Bergantim, Roman Hájek, Cristina Joao, Alexandros Leonidakis, Giorgos Cheliotis, Pieter Sonneveld, Efstathios Kastritis, Ashutosh D Wechalekar
The management of light chain (AL) amyloidosis in Europe: clinical characteristics, treatment patterns, and efficacy outcomes between 2004 and 2018. Blood cancer journal 13 (1) (2023)
Giovanni Palladini, Stefan O Schönland, Giampaolo Merlini, Paolo Milani, Arnaud Jaccard, Frank Bridoux, Meletios- Athanasios Dimopoulos, Sriram Ravichandran, Ute Hegenbart, Wilfried Roeloffzen, M Teresa Cibeira, Hermine Agis, Monique C Minnema, Rui Bergantim, Roman Hájek, Cristina Joao, Alexandros Leonidakis, Giorgos Cheliotis, Pieter Sonneveld, Efstathios Kastritis, Ashutosh D Wechalekar
The management of light chain (AL) amyloidosis in Europe: clinical characteristics, treatment patterns, and efficacy outcomes between 2004 and 2018. Blood cancer journal 13 (1) (2023)
Nathalie Forgeard, Dikelele Elessa, Alexander Carpinteiro, Karim Belhadj, Monique C Minnema, Murielle Roussel, Antoine Huart, Vincent Javaugue, Laurent Pascal, Bruno Royer, Alexis Talbot, Romain Gounot, Ute Hegenbart, Stefan O Schönland, Lionel Karlin, Stephanie Harel, Efstathios Kastritis, Frank Bridoux, Arnaud Jaccard, Bertrand Arnulf
Teclistamab in relapsed or refractory AL amyloidosis, a multinational retrospective case series. Blood (2023)
Giovanni Palladini, Stefan O Schönland, Giampaolo Merlini, Paolo Milani, Arnaud Jaccard, Frank Bridoux, Meletios- Athanasios Dimopoulos, Sriram Ravichandran, Ute Hegenbart, Wilfried Roeloffzen, M Teresa Cibeira, Hermine Agis, Monique C Minnema, Rui Bergantim, Roman Hájek, Cristina Joao, Alexandros Leonidakis, Giorgos Cheliotis, Pieter Sonneveld, Efstathios Kastritis, Ashutosh D Wechalekar
The management of light chain (AL) amyloidosis in Europe: clinical characteristics, treatment patterns, and efficacy outcomes between 2004 and 2018. Blood cancer journal 13 (1) (2023)
Sebastian Köhrer, Tobias Dittrich, Martin Schorb, Niels Weinhold, Isabella Haberbosch, Mandy Boermel, Gabor Pajor, Hartmut Goldschmidt, Carsten Müller-Tidow, Marc S Raab, Lukas John, Anja Seckinger, Alexander Brobeil, Peter Dreger, Tamás Tornóczky, László Pajor, Ute Hegenbart, Stefan O Schönland, Yannick Schwab, Alwin Krämer
High-throughput electron tomography identifies centriole over-elongation as an early event in plasma cell disorders. Leukemia (2023)
Giovanni Palladini, Stefan O Schönland, Giampaolo Merlini, Paolo Milani, Arnaud Jaccard, Frank Bridoux, Meletios- Athanasios Dimopoulos, Sriram Ravichandran, Ute Hegenbart, Wilfried Roeloffzen, M Teresa Cibeira, Hermine Agis, Monique C Minnema, Rui Bergantim, Roman Hájek, Cristina Joao, Alexandros Leonidakis, Giorgos Cheliotis, Pieter Sonneveld, Efstathios Kastritis, Ashutosh D Wechalekar
The management of light chain (AL) amyloidosis in Europe: clinical characteristics, treatment patterns, and efficacy outcomes between 2004 and 2018. Blood cancer journal 13 (1) (2023)
Giovanni Palladini, Stefan O Schönland, Giampaolo Merlini, Paolo Milani, Arnaud Jaccard, Frank Bridoux, Meletios- Athanasios Dimopoulos, Sriram Ravichandran, Ute Hegenbart, Wilfried Roeloffzen, M Teresa Cibeira, Hermine Agis, Monique C Minnema, Rui Bergantim, Roman Hájek, Cristina Joao, Alexandros Leonidakis, Giorgos Cheliotis, Pieter Sonneveld, Efstathios Kastritis, Ashutosh D Wechalekar
The management of light chain (AL) amyloidosis in Europe: clinical characteristics, treatment patterns, and efficacy outcomes between 2004 and 2018. Blood cancer journal 13 (1) (2023)
Julian Baur, Natalie Berghaus, Sarah Schreiner, Ute Hegenbart, Stefan O Schönland, Sebastian Wiese, Stefanie Huhn, Christian Haupt
Identification of AL proteins from 10 λ-AL amyloidosis patients by mass spectrometry extracted from abdominal fat and heart tissue. Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis (2022)
Maximilian Steinebrei, Juliane Gottwald, Julian Baur, Christoph Roecken, Ute Hegenbart, Stefan O Schönland, Matthias Schmidt
Cryo-EM structure of an ATTRwt amyloid fibril from systemic non-hereditary transthyretin amyloidosis. Nature communications 13 (1) (2022)
Andrea Havasi, Cihan Heybeli, Nelson Leung, Avital Angel-Korman, Vaishali Sanchorawala, Oliver Cohen, Ashutosh D Wechalekar, Frank Bridoux, Insara Jaffer, Victoria Gutgarts, Hani Hassoun, Maya Levinson, Cara Rosenbaum, Paolo Milani, Giovanni Palladini, Giampaolo Merlini, Ute Hegenbart, Stefan O Schönland, Kaya Veelken, Alexander Pogrebinsky, Gheorghe Doros, Heather J Landau
Outcomes of renal transplantation in patients with AL amyloidosis: an international collaboration through The International Kidney and Monoclonal Gammopathy Research Group. Blood cancer journal 12 (8) (2022)
Juergen Finke, Claudia Schmoor, Matthias Stelljes, Andreas Burchert, Peter Dreger, Ute Hegenbart, Eva-Maria Wagner-Drouet, Martin Bornhäuser, Kristina Sohlbach, Natalie Schub, Christian Reicherts, Guido Kobbe, Bertram Glass, Hartmut Bertz, Olga Grishina
Thiotepa-fludarabine-treosulfan conditioning for 2nd allogeneic HCT from an alternative unrelated donor for patients with AML: a prospective multicenter phase II trial. Bone marrow transplantation 57 (11) (2022)
Eli Muchtar, Angela Dispenzieri, Brendan Wisniowski, Giovanni Palladini, Paolo Milani, Giampaolo Merlini, Stefan O Schönland, Kaya Veelken, Ute Hegenbart, Susan M Geyer, Shaji K Kumar, Efstathios Kastritis, Meletios- Athanasios Dimopoulos, Michaela Liedtke, Ronald Witteles, Vaishali Sanchorawala, Raphael Szalat, Heather J Landau, Erica Petrlik, Suzanne Lentzch, Alexander Coltoff, Joan Bladé, Maria Teresa Cibeira, Oliver Cohen, Darren Foard, Ashutosh Wechalekar, Morie A Gertz
Graded Cardiac Response Criteria for Patients With Systemic Light Chain Amyloidosis. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2022)
Simone K Feurstein, Julian Zoller, Constantin Schwab, Sarah Schreiner, Heiko Mundt, Iris Breitkreutz, Brigitte Schneider, Jörg Beimler, Martin Zeier, Rüdiger Waldherr, Stefan Gröschel, Carsten Müller-Tidow, Stefan O Schönland, Ute Hegenbart
Concurrent light chain amyloidosis and proximal tubulopathy: Insights into different aggregation behavior-A case report. EJHaem 3 (4) (2022)
Caroline Pabst, Louise Benning, Nora Liebers, Maike Janssen, Leandra Caille, Claudius Speer, Lixiazi He, Maria-Luisa Schubert, Laura Simons, Ute Hegenbart, Stefan O Schönland, Aleksandar Radujkovic, Michael Schmitt, Paul Schnitzler, Carsten Müller-Tidow, Sascha Dietrich, Peter Dreger, Thomas Luft
Humoral Responses and Chronic GVHD Exacerbation after COVID-19 Vaccination Post Allogeneic Stem Cell Transplantation. Vaccines 10 (2) (2022)
Sophie Anker, Katrin Hinderhofer, Julian Baur, Christian Haupt, Christoph Röcken, Jörg Beimler, Martin Zeier, Markus Weiler, Elke Wühl, Christoph Kimmich, Stefan O Schönland, Ute Hegenbart
Lysozyme amyloidosis-a report on a large German cohort and the characterisation of a novel amyloidogenic lysozyme gene variant. Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis (2022)
Vaishali Sanchorawala, Mario Boccadoro, Morie A Gertz, Ute Hegenbart, Efstathios Kastritis, Heather J Landau, Peter Mollee, Ashutosh Wechalekar, Giovanni Palladini
Guidelines for high dose chemotherapy and stem cell transplantation for systemic AL amyloidosis: EHA-ISA working group guidelines. Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis (2021)
Lynn Radamaker, Julian Baur, Stefanie Huhn, Christian Haupt, Ute Hegenbart, Stefan Schönland, Akanksha Bansal, Matthias Schmidt, Marcus Fändrich
Cryo-EM reveals structural breaks in a patient-derived amyloid fibril from systemic AL amyloidosis. Nature communications 12 (1) (2021)
Christoph R Kimmich, Tobias Terzer, Axel Benner, Timon Hansen, Alexander Carpinteiro, Tobias Dittrich, Kaya Veelken, Anna Jauch, Stefanie Huhn, Marco Basset, Hartmut Goldschmidt, Carsten Müller-Tidow, Stefan O Schönland, Ute Hegenbart
Daratumumab, lenalidomide, and dexamethasone in systemic light-chain amyloidosis: High efficacy, relevant toxicity and main adverse effect of gain 1q21. American journal of hematology 96 (7) (2021)
Lynn Radamaker, Sara Karimi-Farsijani, Giada Andreotti, Julian Baur, Matthias Neumann, Sarah Schreiner, Natalie Berghaus, Raoul Motika, Christian Haupt, Paul Walther, Volker Schmidt, Stefanie Huhn, Ute Hegenbart, Stefan O Schönland, Sebastian Wiese, Clarissa Read, Matthias Schmidt, Marcus Fändrich
Role of mutations and post-translational modifications in systemic AL amyloidosis studied by cryo-EM. Nature communications 12 (1) (2021)
Jonathan Schönfelder, Peter Benedikt Pfeiffer, Tejaswini Pradhan, Johan Bijzet, Bouke P C Hazenberg, Stefan O Schönland, Ute Hegenbart, Bernd Reif, Christian Haupt, Marcus Fändrich
Protease resistance of ex vivo amyloid fibrils implies the proteolytic selection of disease-associated fibril morphologies. Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis (2021)
Charlie N Saunders, Subhayan Chattopadhyay, Stefanie Huhn, Niels Weinhold, Per Hoffmann, Markus Maria Nöthen, Karl-Heinz Jöckel, Börge Schmidt, Stefano Landi, Hartmut Goldschmidt, Paolo Milani, Giampaolo Merlini, Dorota Rowcieno, Philip Hawkins, Ute Hegenbart, Giovanni Palladini, Ashutosh Wechalekar, Stefan O Schönland, Asta Försti, Richard Houlston, Kari Hemminki
Search for AL amyloidosis risk factors using Mendelian randomization. Blood advances 5 (13) (2021)
Daniel Authier, Ute Hegenbart, Fabian Pohl, Andreas Rosenwald, Stefan Kircher, Karin Menhart, Markus Perl, Jindrich Cerny, Stephanie Mayer, Wolfgang Herr, Matthias Grube
Low dose stereotactic irradiation and dexamethasone in primary cerebral light chain deposition disease (LCDD). Leukemia & lymphoma 62 (9) (2021)
Lorenz Selberg, Peter Stadtherr, Sascha Dietrich, T Hien Tran, Thomas Luft, Ute Hegenbart, Andrea Bondong, Julia Meissner, Nora Liebers, Michael Schmitt, Anthony Dick Ho, Carsten Müller-Tidow, Peter Dreger
The impact of allogeneic hematopoietic cell transplantation on the mortality of poor-risk non-Hodgkin lymphoma: an intent-to-transplant analysis. Bone marrow transplantation 56 (1) (2020)
Matthias N Ungerer, Ernst Hund, Jan Christoph Purrucker, Laura Huber, Christoph Kimmich, Fabian Aus dem Siepen, Selina Hein, Arnt V Kristen, Katrin Hinderhofer, Jennifer C Hayes, Stefan O Schönland, Ute Hegenbart, Markus Weiler
Real-world outcomes in non-endemic hereditary transthyretin amyloidosis with polyneuropathy: a 20-year German single-referral centre experience. Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis 28 (2) (2020)
Lynn Radamaker, Yin-Hsi Lin, Karthikeyan Annamalai, Stefanie Huhn, Ute Hegenbart, Stefan O Schönland, Güenter Fritz, Matthias Schmidt, Marcus Fändrich
Cryo-EM structure of a light chain-derived amyloid fibril from a patient with systemic AL amyloidosis. Nature communications 10 (1) (2019)
Subhayan Chattopadhyay, Hauke Thomsen, Niels Weinhold, Iman Meziane, Stefanie Huhn, Miguel Inacio da Silva Filho, Pavel Vodicka, Ludmila Vodickova, Per Hoffmann, Markus M Nöthen, Karl-Heinz Jöckel, Börge Schmidt, Stefano Landi, Roman Hajek, Göran Hallmans, Ulrika Pettersson-Kymmer, Claes Ohlsson, Paolo Milani, Giampaolo Merlini, Dorota Rowcieno, Philip Hawkins, Ute Hegenbart, Giovanni Palladini, Ashutosh Wechalekar, Stefan O Schönland, Richard S Houlston, Hartmut Goldschmidt, Kari Hemminki, Asta Försti
Eight novel loci implicate shared genetic etiology in multiple myeloma, AL amyloidosis, and monoclonal gammopathy of unknown significance. Leukemia 34 (4) (2019)
Tomas Pika, Ute Hegenbart, Pavla Flodrova, Bettina Maier, Christoph Kimmich, Stefan O Schönland
First report of ibrutinib in IgM-related amyloidosis: few responses, poor tolerability, and short survival. Blood 131 (3) (2017)
Kaya Veelken, Stefan O Schönland, Georg Gdynia, Tim Weber, Norbert Blank, Ute Hegenbart
Diagnostic work up of an adult female patient with systemic AA amyloidosis revealing the cause of infantile mental retardation. Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis 25 (1) (2017)

Ute Hegenbart.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Ute Hegenbart